it is very promising in vivo and in vitro, esp for lung metastasis
”In a study published in Clinical Cancer Research, the researchers demonstrate that the compound can reduce lung metastasis in mice by over 90 per cent, while also shrinking the primary tumour site.”
In vivo/vitro latest immunotherapy proof of concept by targeting IL30 in prostate cancer
Cancer in Lymph Nodes May Help Tumors Spread by Enlisting Immune Cells
Management of the Metastases in Oligometastatic Prostate Cancer 64Cu-SAR-bisPSMA Is Safe and Highly Effective in Detecting Tumours in Prostate Cancer Patients: results from COBRA trial
Cancer Deaths Plummet... but not Prostate
